Condition: Cytomegalovirus Viraemia · Sponsor: Murdoch Childrens Research Institute
This study is being conducted at seven major children's hospitals in Australia and New Zealand to test a new approach for treating a virus, called cytomegalovirus in children with weakened immune systems. The researchers want to find out if using a web app to customise the dose of a medication called ganciclovir is better at clearing the virus over a six-week period compared to the standard method of giving the medication.
This description comes directly from the study's public registry record.
Alice Lei · +61 0433 903 448 · alice.lei2@rch.org.au
Sharelle Joseland · +61 0410052823 · sharelle.joseland2@rch.org.au
Always discuss trial participation with your own doctor first.
| Sydney Children's Hospital | Sydney, New South Wales, Australia | Recruiting |
| The Children's Hospital at Westmead | Sydney, New South Wales, Australia | Recruiting |
| Queensland Children's Hospital | Brisbane, Queensland, Australia | Recruiting |
| The Royal Children's Hospital | Melbourne, Victoria, Australia | Recruiting |
| Monash Children's Hospital | Melbourne, Victoria, Australia | Recruiting |
| Perth Children's Hospital | Perth, Western Australia, Australia | Recruiting |
| Starship Children's Hospital | Auckland, North Island, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06574789